<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03384875</url>
  </required_header>
  <id_info>
    <org_study_id>2017-001</org_study_id>
    <nct_id>NCT03384875</nct_id>
  </id_info>
  <brief_title>CytoSorb速 Reduction of FREee Hemoglobin/Acute Kidney Injury (AKI) During Cardiac Surgery</brief_title>
  <acronym>REFRESH II-AKI</acronym>
  <official_title>CytoSorb速 Reduction of FREee Hemoglobin/Acute Kidney Injury (AKI) During Cardiac Surgery (REFRESH II Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CytoSorbents, Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CytoSorbents, Inc</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, multi-center, randomized, blinded, pivotal clinical study. Subjects will be
      randomized in a 1:1 ratio to either standard of care (SOC) alone or standard of care plus
      treatment with the CytoSorb速 device.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 19, 2018</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence or severity of acute kidney injury (AKI) in the first 48 hours after cardiopulmonary pulmonary bypass (CPB)</measure>
    <time_frame>From start of CPB through 48 hours after CPB</time_frame>
    <description>Kidney Disease Improving Global Outcomes (KDIGO) definitions for AKI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in maximum plasma free hemoglobin and activated complement from start of CPB through post-surgery day 3</measure>
    <time_frame>From start of CPB through post-surgery day 3</time_frame>
    <description>Blood sample indices of effects from cardiac surgery with CPB</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severity or duration of AKI in the first 7 days after CPB</measure>
    <time_frame>From start of CPB through 7 days post-cardiac surgery</time_frame>
    <description>KDIGO definitions for AKI</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Elective Cardiac Surgery</condition>
  <arm_group>
    <arm_group_label>CytoSorb Device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard of care plus treatment with CytoSorb device installed on the Cardiopulmonary bypass (CPB) machine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Standard of care</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CytoSorb</intervention_name>
    <description>To evaluate the safety and performance of the CytoSorb速 device to decrease the incidence or severity of acute kidney injury (AKI)</description>
    <arm_group_label>CytoSorb Device</arm_group_label>
    <arm_group_label>Control</arm_group_label>
    <other_name>CytoSorb device used during cardiopulmonary bypass (CPB)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled for non-emergent cardiac surgery requiring CPB for i) heart valve
             replacement with any other procedure, without hypothermic circulatory arrest (HCA), or
             ii) aortic reconstruction with or without another procedure, with HCA

        Exclusion Criteria:

          -  Weight &lt; 99 lbs - &gt; 383 lbs

          -  Isolated Coronary Artery Bypass Graft

          -  Pregnant women

          -  Life expectancy of &lt; 14 days

          -  End stage organ disease

          -  Active infection

          -  Correction of a congenital heart defect

          -  Contraindication to anticoagulation with heparin

          -  Minimally invasive surgery implantation (TAVI) or transcatheter aortic valve
             replacement (TAVR)

          -  Declined informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sally Palmer</last_name>
    <phone>732-398-5442</phone>
    <email>spalmer@cytosorbents.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hilary Jordan Dion, PA, BA</last_name>
    <phone>508 691 7020</phone>
    <email>hjordan@boston-biomedical.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Presbyterian Hospital Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lyn Goldsmith, RN</last_name>
    </contact>
    <investigator>
      <last_name>Argenziano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 20, 2017</study_first_submitted>
  <study_first_submitted_qc>December 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 28, 2017</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CytoSorb device</keyword>
  <keyword>Plasma free hemoglobin</keyword>
  <keyword>inflammation</keyword>
  <keyword>extracorporeal cardiopulmonary bypass</keyword>
  <keyword>cardiopulmonary bypass</keyword>
  <keyword>Acute Kidney Injury</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

